| P2093 | author name string | Kyoichi Mizuno | |
| | Masamichi Takano | |
| | Fumiyuki Ishibashi | |
| | Ryota Uemura | |
| | Kentaro Okamatsu | |
| | Shinya Yokoyama | |
| | Koji Seimiya | |
| P2860 | cites work | Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina | Q71948888 |
| | HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis | Q77700153 |
| | Are we mortgaging the medical profession? | Q95814757 |
| | The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 |
| | Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 |
| | Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 |
| | Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization | Q31956534 |
| | Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial | Q34517714 |
| | Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history and the effect of thrombolysis | Q34744732 |
| | Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients | Q38459247 |
| | Coronary Plaque Disruption | Q40459835 |
| | Molecular bases of the acute coronary syndromes | Q40530238 |
| | Angioscopic predictors of early adverse outcome after coronary angioplasty in patients with unstable angina and non-Q-wave myocardial infarction | Q40936290 |
| | Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. | Q41169190 |
| | Angioscopic coronary macromorphology in patients with acute coronary disorders | Q41839591 |
| | Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways | Q43961145 |
| | Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies | Q43974033 |
| | Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. | Q47924135 |
| | In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings | Q48507360 |
| | Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes | Q52480523 |
| | Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. | Q52543442 |
| | Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. | Q53005914 |
| | Platelet Deposition on Eroded Vessel Walls at a Stenotic Shear Rate Is Inhibited by Lipid-Lowering Treatment With Atorvastatin | Q60924263 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 680-686 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy | |
| P478 | volume | 42 | |